183 related articles for article (PubMed ID: 36402613)
1. Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignancies.
Elshami M; Ahmed FA; Hue JJ; Kakish H; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
Surgery; 2023 Feb; 173(2):289-298. PubMed ID: 36402613
[TBL] [Abstract][Full Text] [Related]
2. Average treatment effect of facility hepatopancreatobiliary cancer volume on survival of non-resected pancreatic adenocarcinoma.
Elshami M; Ahmed FA; Kakish H; Hue JJ; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
HPB (Oxford); 2022 Nov; 24(11):1878-1887. PubMed ID: 35961931
[TBL] [Abstract][Full Text] [Related]
3. A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment.
Elshami M; Hue JJ; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Chavin KD; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
HPB (Oxford); 2022 Aug; 24(8):1280-1290. PubMed ID: 35063353
[TBL] [Abstract][Full Text] [Related]
4. Facility Type is Another Factor in the Volume-Outcome Relationship for Complex Hepatopancreatobiliary Procedures.
Wilson GC; Geller DA
Ann Surg Oncol; 2019 Nov; 26(12):3811-3812. PubMed ID: 31372869
[No Abstract] [Full Text] [Related]
5. Trends and disparities in the utilization of systemic chemotherapy in patients with metastatic hepato-pancreato-biliary cancers.
Elshami M; Ahmed FA; Kakish H; Hue JJ; Hoehn RS; Rothermel LD; Bajor D; Mohamed A; Selfridge JE; Ammori JB; Hardacre JM; Winter JM; Ocuin LM
HPB (Oxford); 2023 Feb; 25(2):239-251. PubMed ID: 36411233
[TBL] [Abstract][Full Text] [Related]
6. Cancers of the large bowel and hepatobiliary tract.
Treat J; Woolley PV
Cancer Chemother Biol Response Modif; 1992; 13():477-92. PubMed ID: 1327046
[No Abstract] [Full Text] [Related]
7. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
[TBL] [Abstract][Full Text] [Related]
8. Brain metastases from hepatopancreatobiliary malignancies.
Bergen ES; Friedrich A; Scherleitner P; Ferreira P; Kiesel B; Widhalm G; Kiesewetter B; Eckert F; Prager GW; Preusser M; Berghoff AS
Clin Exp Metastasis; 2023 Apr; 40(2):177-185. PubMed ID: 36947280
[TBL] [Abstract][Full Text] [Related]
9. Cancers of the large bowel and hepatobiliary system.
Treat J; Ahlgren JD; Woolley PV
Cancer Chemother Biol Response Modif; 1987; 9():264-70. PubMed ID: 2856336
[No Abstract] [Full Text] [Related]
10. Cancers of the large bowel and hepatobiliary tract.
Treat J; Woolley PV
Cancer Chemother Biol Response Modif; 1991; 12():469-89. PubMed ID: 1657090
[No Abstract] [Full Text] [Related]
11. Cancers of the large bowel and hepatobiliary tract.
Treat J; Woolley PV
Cancer Chemother Biol Response Modif; 1990; 11():460-75. PubMed ID: 2171612
[No Abstract] [Full Text] [Related]
12. Gastrointestinal cancer in the elderly.
Wallach CB; Kurtz RC
Gastroenterol Clin North Am; 1990 Jun; 19(2):419-32. PubMed ID: 2163983
[TBL] [Abstract][Full Text] [Related]
13. Cancers of the large bowel and hepatobiliary tract.
d'Entremont TS; Stevenson JP
Cancer Chemother Biol Response Modif; 2002; 20():435-62. PubMed ID: 12703219
[No Abstract] [Full Text] [Related]
14. Surgical outcomes of pulmonary metastasis from hepatopancreatobiliary carcinomas: a comparison with pulmonary metastasis from colorectal carcinomas.
Kaiho T; Suzuki H; Yamamoto T; Morimoto J; Sakairi Y; Wada H; Nakajima T; Yoshino I
Surg Today; 2019 Sep; 49(9):762-768. PubMed ID: 30859309
[TBL] [Abstract][Full Text] [Related]
15. The microbiome and hepatobiliary-pancreatic cancers.
Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
[TBL] [Abstract][Full Text] [Related]
16. The association between facility case volume and overall survival in patients with metastatic renal cell carcinoma in the targeted therapy era.
Chen YW; Ornstein MC; Wood LS; Allman KD; Martin A; Beach J; Gilligan T; Garcia JA; Rini BI
Urol Oncol; 2018 Oct; 36(10):470.e19-470.e29. PubMed ID: 30131292
[TBL] [Abstract][Full Text] [Related]
17. Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study.
Yu J; Refsum E; Helsingen LM; Folseraas T; Ploner A; Wieszczy P; Barua I; Jodal HC; Melum E; Løberg M; Blom J; Bretthauer M; Adami HO; Kalager M; Ye W
United European Gastroenterol J; 2022 Mar; 10(2):212-224. PubMed ID: 35107865
[TBL] [Abstract][Full Text] [Related]
18. Nonsurgical Approaches to Treat Biliary Tract and Liver Tumors.
Green BL; House MG
Surg Oncol Clin N Am; 2019 Oct; 28(4):573-586. PubMed ID: 31472906
[TBL] [Abstract][Full Text] [Related]
19. Right portal vein embolization with absolute ethanol in major hepatic resection for hepatobiliary malignancy.
Sofue K; Arai Y; Shimada K; Takeuchi Y; Kobayashi T; Satake M; Sugimura K
Br J Surg; 2014 Aug; 101(9):1122-8. PubMed ID: 24920297
[TBL] [Abstract][Full Text] [Related]
20. Claudin-4 differentiates biliary tract cancers from hepatocellular carcinomas.
Lódi C; Szabó E; Holczbauer A; Batmunkh E; Szíjártó A; Kupcsulik P; Kovalszky I; Paku S; Illyés G; Kiss A; Schaff Z
Mod Pathol; 2006 Mar; 19(3):460-9. PubMed ID: 16439986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
